Aislyn Boran

Senior Director, Translational Strategy

Daiichi Sankyo

Alain Beck

Senior Director, Biologics Chemistry, Manufacturing & Controls Developability

Pierre Fabre

Alexander Bijman

Director, Large Molecule External Manufacturing Technical Operations

MSD

Ali Salanti

Chief Executive Officer

VAR2 Pharmaceuticals

Alireza Tafazzol

Senior Scientist II, Oncology Bioinformatics

AbbVie

Alisdair Hearn

Senior Process Development Scientist

Sterling Pharma Solutions

Andras Strassz

Chief Medical Officer

Heidelberg Pharma

Andre Unglert

Director, Commercial Development, Bioconjugates

Lonza

Andrea Galbiati

Group Leader

Philochem

Andreas Pahl

CEO

Heidelberg Pharma

Benjamin Thomas

Senior Vice President, External Innovation

Oxford BioTherapeutics

Benny Yang

Chief Scientific Officer

Biocytogen

Bertrand Cottineau

R&D Group Head

Axplora

BonJoon Goo

Senior Manager, Business Development

AbTis

Callum Angus

Senior Market Analyst

Hanson Wade Intelligence

Colm Reddington

Senior Director, Global Regulatory CMC

AstraZeneca

Conor Barry

Associate Vice President & Global Head, Bioconjugate Development

Piramal Pharma Solutions

Daisy Sun

Principal Scientist, Cell-Based Science

MSD

Daniel Bending

Postdoctoral researcher

Eli Lilly

Daniel Schulz-Jander

Senior Director, Bioanalysis (Mass Spectrometry)

QPS

David Bramhill

President & Founder

Bramhill Biological Consulting

David Garcia Illescas

Medical Oncologist, Gynaecological Cancer Programme

University Hospital Vall d’Hebron

David Huang

Head, Medicinal Chemistry

OBI Pharma

Dhiraj Gambhire

Global Clinical Lead, Enhertu, Executive Medical Director

Daiichi Sankyo

Dongzhou Jeffrey Liu

Chief Scientific Officer

Huadong Medicine

Eider Valle-Encinas

Scientific Business Development Manager

HUB Organoids

Elizabeth Love

Scientific Leader, ADC Platform

GSK

Federico Riccardi Sirtori

Director & Head, NBE-DMPK Innovative Bioanalytics

Merck KGaA

Floris van Delft

Head, R&D

Synaffix

Francois D’Hooge

Senior Manager, CMC Management

Daiichi Sankyo

Garret Cornelison

Senior Principal Scientist

Pfizer

Gavin Bennet

Senior Director, Drug Development

Bicycle Therapeutics

Gavin Birch

Manager, Chemistry

Abzena

Gilles Gallant

Chief Development Officer

Mythic Therapeutics

Giorgio Salciarini

head of sales

BSP Pharmaceuticals

Gordon Rigg

Principal Consultant

Apex Biologics Consulting

Greg Adams

Independent Consultant

Greg Thurber

Associate Professor & Chair, Graduate Education

University of Michigan

Guitao Wang

President, Research & Development

Coherent Biopharma

Hans-Georg Lerchen

Chief Scientific Officer

Vincerx Pharma

Hayley Jackman

Director, CMC Regulatory Affairs

AstraZeneca

Heidi Wang

Chief Executive Officer

OBI Pharma

Hendrik Gruß

Director, Chemistry

Heidelberg Pharma

Hiroyuki Kogai

Scientist

Eisai

Irena Adkins

Director, Pharmacology

SOTIO Biotech

Jake Morris

Senior Account Manager & ADC Insights Lead

Beacon by Hanson Wade

Jamie Rich

Senior Director, Technology, ADC Therapeutics Group

Zymeworks

Jiazhen Chen

Director, External Innovations

BioNTech

Jinwon Jung

Senior Director, Protein Engineering

ABL Bio

Joanna Opalinska

Senior Director of Clinical Development

GlaxoSmithKline

Johanna Midelet

Head, Bioconjugation & Chemistry

Abzena

John Lambert

Independent Consultant & Honorary Professor

Queens University Belfast

Jon Travers

Senior Director, External Innovation & Early Development

Ipsen

Jonas Béal

Director, Solution Strategy

Owkin

Justin Mason-Home

Director

HPAPI Project Services Limited

Jutta Deckert

Vice President, Research & Development

Iksuda Therapeutics

Kati Räsänen

Independent Consultant

Kerstin Hofer

Matrix & Science Lead

Roche

Kevin Hamblett

Senior Director, ADC Biology

Pfizer

Kurt Pike

Senior Director, External Innovation

Johnson & Johnson

Lance Cadang

Scientist III

Genentech

Lena Jonsson

Product Strategy Manager

Cytiva

Lenka Sadilkova

Director, Non-Clinical Projects

Mablink Bioscience, an Eli Lilly Subsidiary

Lisa McDermott

Director, Process & Analytical Development

Merck

Lizzy Zhao

Senior Scientist

Regeneron

Llorente Bonaga

Senior Director, Global Regulatory Affairs & Clinical Safety, CMC

MSD

Lolke de Haan

Vice President, Toxicology

ADC Therapeutics

Lucas Donigian

VP BD

Zymeworks

Manel Kraiem

Chief Development Officer

Skymab Therapeutics

Marcel Rieker

Principal Scientist & Team Leader PROxAb Shuttle

Merck KGaA

Maria Dahl

Chief Operating Officer & Head of Innovent Biologics

Innovent Biologics

Marie Zhu

Chief Technology Officer

WuXi XDC

Marisa Schmitt

Director, Bioanalysis

Heidelberg Pharma

Martin Steegmaier

Chief Scientific Officer

SOTIO Biotech

Max Lee

Associate Director

AstraZeneca

Megan Rice

Senior Scientist

AstraZeneca

Meike Roskamp

Director, Bioconjugation

Daiichi Sankyo

Melanie Derde

Head, Bioconjugation Operations

Axplora

Michael Chisamore

Executive Medical Director (Distinguished Scientist), Oncology Clinical Research, Early Development

MSD

Michael Conner

Investigator & In Vitro Scientist, Extracellular Tumour Cell Targeting Research Unit

GSK

Michael Trose

Manager, Process Technologist, MSAT Bioconjugates

Lonza

Ming-Tain Lai

Chief Scientific Officer

OBI Pharma

Nicholas Willumsen

Director & Head, Oncology

Nordic Bioscience

Nimish Gera

Vice President, Biologics

Mythic Therapeutics

NingNing Ma

Professor

Shenyang Pharmaceutical University

Norbert Prenzel

Head of Business Development & Licensing

SOTIO Biotech

Osama Chahrour

Principal Scientist, Chemical Development

AstraZeneca

Paul Wolstenholme-Hogg

Vice President, Medicinal Chemistry

ADC Therapeutics

Pavan Vajjah

Executive Director, Global Head ADC Clinical Pharmacology & Safety Sciences

AstraZeneca

Penelope Drake

Head, R&D Bioconjugates

Catalent Biologics

Philip Mpagi Bwogi

Director CMC Program Leadership

BioNTech

Radha Ramkumar

Vice President, Global Team Leader, Oncology Development

Daiichi Sankyo

Rakesh Dixit

President & Chief Executive Officer

Bionavigen Oncology

Robert Lutz

Chief Science Officer

Iksuda Therapeutics

Rohtash Kumar

Senior Vice President, Development Operations & Chief Technology Officer

Veranova

Sarah-Jane Neuberth

Group Leader, In Vivo Biology

Heidelberg Pharma

Sebastian Birkedal Kristensen

Senior Scientist

Byondis

Sharsti Sandall

Executive Director, Oncology Research

Pfizer

Shujing Wang

Senior Director, Drug Product Development

AsymBio

Shuntaro Tsukamoto

Scientist

Eisai

Simon Chivers

Managing Director & Independent Consultant

Integrated Biologix

Simon Jiang

Vice President & Head, Scientific Engagement

Lide Biotech

Sophie Bertrand

Scientific Team Leader

GSK

Sumiko Okubo

Medical Director, Oncology Early Development

AbbVie

Tomohiro Fujii

Researcher

Ajinomoto Bio-Pharma Services

Travis Biechele

Vice President, Research

Shasqi

Uchechukwu Okorji-Obike

Senior Scientist, Bioassay Development

AstraZeneca

Venkatesh Pilla Reddy

Senior Director, Global PKPD & Pharmacometrics

Eli Lilly

Willem Sloot

Associate Director, Non-Clinical Drug Safety

Merck KGaA

William Olughu

Senior Principal Scientist

Ipsen

Xiaona Jing

Senior Vice President, Global Product Development & Partnering

Multitude Therapeutics

Xiaoxiao Wang

Vice President, Antibody Discovery & ADC Platform

Nona Biosciences

Ying Buechler

Chief Technology Officer

Ambrx, a Johnson & Johnson Company

Yu-Shin Hsu

Research Analyst

Beacon by Hanson Wade